Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of GBP 543.18 million. The enterprise value is 909.08 million.

Market Cap	543.18M
Enterprise Value	909.08M

Important Dates

The next estimated earnings date is Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Dr. Martens has 963.09 million shares outstanding. The number of shares has decreased by -1.56% in one year.

Current Share Class	n/a
Shares Outstanding	963.09M
Shares Change (YoY)	-1.56%
Shares Change (QoQ)	-3.27%
Owned by Insiders (%)	2.06%
Owned by Institutions (%)	45.80%
Float	515.11M

Valuation Ratios

The trailing PE ratio is 8.06 and the forward PE ratio is 19.87.

PE Ratio	8.06
Forward PE	19.87
PS Ratio	0.63
PB Ratio	1.47
P/TBV Ratio	n/a
P/FCF Ratio	3.63
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.71, with an EV/FCF ratio of 6.07.

EV / Earnings	13.14
EV / Sales	1.04
EV / EBITDA	4.71
EV / EBIT	7.19
EV / FCF	6.07

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 1.30.

Current Ratio	2.85
Quick Ratio	1.14
Debt / Equity	1.30
Debt / EBITDA	2.47
Debt / FCF	3.19
Interest Coverage	3.93

Financial Efficiency

Return on equity (ROE) is 17.92% and return on invested capital (ROIC) is 9.29%.

Return on Equity (ROE)	17.92%
Return on Assets (ROA)	8.12%
Return on Capital (ROIC)	9.29%
Revenue Per Employee	333,498
Profits Per Employee	26,312
Employee Count	2,630
Asset Turnover	0.90
Inventory Turnover	1.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.22% in the last 52 weeks. The beta is 0.10, so Dr. Martens's price volatility has been lower than the market average.

Beta (5Y)	0.10
52-Week Price Change	-50.22%
50-Day Moving Average	56.20
200-Day Moving Average	74.23
Relative Strength Index (RSI)	49.95
Average Volume (20 Days)	1,654,076

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of GBP 877.10 million and earned 69.20 million in profits. Earnings per share was 0.07.

Revenue	877.10M
Gross Profit	575.20M
Operating Income	126.40M
Pretax Income	93.00M
Net Income	69.20M
EBITDA	141.70M
EBIT	126.40M
Earnings Per Share (EPS)	0.07

Full Income Statement

Balance Sheet

The company has 111.10 million in cash and 477.00 million in debt, giving a net cash position of -365.90 million or -0.38 per share.

Cash & Cash Equivalents	111.10M
Total Debt	477.00M
Net Cash	-365.90M
Net Cash Per Share	-0.38
Equity (Book Value)	368.20M
Book Value Per Share	0.38
Working Capital	283.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 167.90 million and capital expenditures -18.20 million, giving a free cash flow of 149.70 million.

Operating Cash Flow	167.90M
Capital Expenditures	-18.20M
Free Cash Flow	149.70M
FCF Per Share	0.16

Full Cash Flow Statement

Margins

Gross margin is 65.58%, with operating and profit margins of 14.41% and 7.89%.

Gross Margin	65.58%
Operating Margin	14.41%
Pretax Margin	10.60%
Profit Margin	7.89%
EBITDA Margin	16.16%
EBIT Margin	14.41%
FCF Margin	17.07%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.71%.

Dividend Per Share	0.03
Dividend Yield	4.71%
Dividend Growth (YoY)	-56.34%
Years of Dividend Growth	2
Payout Ratio	83.53%
Buyback Yield	1.56%
Shareholder Yield	6.27%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Martens has an Altman Z-Score of 5.53.

Altman Z-Score	5.53
Piotroski F-Score	n/a